Aloxiprin: Difference between revisions
Matt Pijoan (talk | contribs) m (Protected "Aloxiprin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 27: | Line 27: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 41: | Line 41: | ||
{{Antithrombotics}} | {{Antithrombotics}} | ||
[[Category:Benzoates]] | [[Category:Benzoates]] | ||
Revision as of 20:55, 8 August 2012
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C18H15AlO9 |
| Molar mass | 402.288 g/mol |
|
WikiDoc Resources for Aloxiprin |
|
Articles |
|---|
|
Most recent articles on Aloxiprin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Aloxiprin at Clinical Trials.gov Clinical Trials on Aloxiprin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Aloxiprin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Aloxiprin Discussion groups on Aloxiprin Directions to Hospitals Treating Aloxiprin Risk calculators and risk factors for Aloxiprin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Aloxiprin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Aloxiprin (or aluminum acetylsalicylate) is a platelet aggregation inhibitor. It is derived from aspirin.[1]
It is also known as "Palaprin Forte".[2]
References
- ↑ CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. PMID 14024235.
- ↑ Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice. 22 (9): 392–4. PMID 4876729.
External links
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Benzoates
- Aluminium compounds
- Drugs